N/A N=62 Diagnostic

Ultrasound Based Acoustic Radiation Force Impulse Imaging

Liver Fibrosis · Liver Inflammation

Bottom Line

View on ClinicalTrials.gov: NCT01781208 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Oct 2016

Primary outcome: Primary: ARFI/VTQ and ARFI/VTIQ Liver Shear Wave Speed vs. Liver Histologic Fibrosis Score — 1.69; 2.01 m/s — p=<0.0001

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: Ultrasound-Based Acoustic Radiation Force Impulse (ARFI) (Device)
Age: Pediatric, Adult
Sex: All
Sponsor: University of Michigan
Primary completion: May 2015

Outcome Measures

Outcome	Result	p-value
PRIMARY ARFI/VTQ and ARFI/VTIQ Liver Shear Wave Speed vs. Liver Histologic Fibrosis Score	1.69; 2.01	<0.0001 sig

Summary

ARFI (Ultrasound-based Acoustic Radiation Force Impulse) will be used during ultrasound guided needle biopsy of the liver of children.

Eligibility Criteria

Inclusion Criteria

18 years of age or younger
Scheduled to have a needle biopsy of the liver at
C.S. Mott Children's Hospital or
Dept. of Radiology at the Univ. of Michigan Hospital
Scheduled to have an abdominal ultrasound to evaluate your liver (with no known liver disease)

Exclusion Criteria

None to list

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01781208). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.